For the first time, a compound was able to restore the health of diseased upper motor neurons — nerve cells…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Maltese people with amyotrophic lateral sclerosis (ALS) do not exhibit mutations in the genes commonly…
Work into moving M102, an investigative treatment for amyotrophic lateral sclerosis…
A method that measures tiny amounts of aggregated TDP-43 protein in the cerebrospinal fluid may have the …
BREN-02, a lab-made form of the human protein engrailed 1 (EN1), has…
The Stentrode, a minimally invasive, fully implanted wireless device that transmits signals from…
A newly identified type of immune cell — a kind of immature neurophil or white blood cell…
Most people with bulbar onset amyotrophic lateral sclerosis (ALS) showed distinct signs of…
BrainStorm Cell Therapeutics is sharing the details of the design of its Phase 3 clinical…
The Muscular Dystrophy Association (MDA) has awarded five new grants totaling more than…